The role of glycodelin in cell differentiation and tumor growth

References

• Kämäräinen M, Julkunen M, Seppälä M. HinfI polymorphism in the human progesterone associated endometrial protein (PAEP) gene. Nucleic Acids Res 1991; 19: 5092
   PubMed Web of Science ®Google Scholar
• Dell A, Morris HR, Easton RL, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppälä M, Clark GF. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J Biol Chem 1995; 270: 24116–26
   PubMed Web of Science ®Google Scholar
• Morris HR, Dell A, Easton RL, Panico M, Koistinen H, Koistinen R, Oehninger S, Patankar MS, Seppälä M, Clark GF. Gender‐specific glycosylation of human glycodelin affects its contraceptive activity. J Biol Chem 1996; 271: 32159–67
   PubMed Web of Science ®Google Scholar
• Seppälä M, Taylor RN, Koistinen H, Koistinen R, Milgrom E. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 2002; 23: 401–30
   PubMed Web of Science ®Google Scholar
• Julkunen M, Koistinen R, Sjöberg J, Rutanen EM, Wahlström T, Seppälä M. Secretory endometrium synthesizes placental protein 14. Endocrinology 1986; 118: 1782–6
   PubMed Web of Science ®Google Scholar
• Taylor RN, Savouret JF, Vaisse C, Vigne JL, Ryan I, Hornung D, Seppälä M, Milgrom E. Promegestone (R5020) and mifepristone (RU486) both function as progestational agonists of human glycodelin gene expression in isolated human epithelial cells. J Clin Endocrinol Metab 1998; 83: 4006–12
   PubMed Web of Science ®Google Scholar
• Arnold JT, Lessey BA, Seppälä M, Kaufman DG. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells. Cancer Res 2002; 62: 79–88
   PubMed Web of Science ®Google Scholar
• Kämäräinen M, Seppälä M, Virtanen I, Andersson LC. Expression of glycodelin in MCF‐7 breast cancer cells induces differentiation into organized acinar epithelium. Lab Invest 1997; 77: 565–73
   PubMed Web of Science ®Google Scholar
• Koistinen H, Seppälä M, Nagy B, Tapper J, Knuutila S, Koistinen R. Glycodelin reduces carcinoma‐associated gene expression in endometrial adenocarcinoma cells. Am J Obstet Gynecol 2005; 193: 1955–60
   PubMed Web of Science ®Google Scholar
• Uchida H, Maruyama T, Nagashima T, Asada H, Yoshimura Y. Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up‐regulation of glycodelin. Endocrinology 2005; 146: 5365–73
   PubMed Web of Science ®Google Scholar
• Hautala L, Koistinen R, Seppälä M, Bützow R, Stenman UH, Laakkonen P, Koistinen H. Glycodelin reduces breast cancer xenograft growth in vivo. Int J Cancer 2008; 123: 2279–84
   PubMed Web of Science ®Google Scholar
• Ohta K, Maruyama T, Uchida H, Ono M, Nagashima T, Arase T, Kajitani T, Oda H, Morita M, Yoshimura Y. Glycodelin blocks progression to S phase and inhibits cell growth: a possible progesterone‐induced regulator for endometrial epithelial cell growth. Mol Hum Reprod 2008; 14: 17–22
   PubMed Web of Science ®Google Scholar
• Uchida H, Maruyama T, Ono M, Ohta K, Kajitani T, Masuda H, Nagashima T, Arase T, Asada H, Yoshimura Y. Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up‐regulation of glycodelin. Endocrinology 2007; 148: 896–902
   PubMed Web of Science ®Google Scholar
• Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006; 5: 769–84
   PubMed Web of Science ®Google Scholar
• Grant S, Easley C, Kirkpatrick P. Vorinostat. Nat Rev Drug Discov 2007; 6: 21–2
   PubMed Web of Science ®Google Scholar
• Uchida H, Maruyama T, Ohta K, Ono M, Arase T, Kagami M, Oda H, Kajitani T, Asada H, Yoshimura Y. Histone deacetylase inhibitor‐induced glycodelin enhances the initial step of implantation. Hum Reprod 2007; 22: 2615–22
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001; 1: 46–54
   PubMed Web of Science ®Google Scholar
• Debnath J, Brugge JS. Modelling glandular epithelial cancers in three‐dimensional cultures. Nat Rev Cancer 2005; 5: 675–88
   PubMed Web of Science ®Google Scholar
• Petersen OW, Ronnov‐Jessen L, Howlett AR, Bissell MJ. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 1992; 89: 9064–8
   PubMed Web of Science ®Google Scholar
• Koistinen H, Seppälä M, Knuutila S, Koistinen R. Extracellular matrix‐induced changes in expression of cell cycle‐related proteins and proteasome components in endometrial adenocarcinoma cells. Gynecol Oncol 2006; 102: 546–51
   PubMed Web of Science ®Google Scholar
• Schroeder JA, Masri AA, Adriance MC, Tessier JC, Kotlarczyk KL, Thompson MC, Gendler SJ. MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation. Oncogene 2004; 23: 5739–47
   PubMed Web of Science ®Google Scholar
• Ren J, Agata N, Chen D, Li Y, Yu WH, Huang L, Raina D, Chen W, Kharbanda S, Kufe D. Human MUC1 carcinoma‐associated protein confers resistance to genotoxic anticancer agents. Cancer Cell 2004; 5: 163–75
   PubMed Web of Science ®Google Scholar
• Crescenzi E, Criniti V, Pianese M, Tecce MF, Palumbo G. Differential expression of antiapoptotic genes in human endometrial carcinoma: bcl‐XL succeeds bcl‐2 function in neoplastic cells. Gynecol Oncol 2000; 77: 419–28
   PubMed Web of Science ®Google Scholar
• Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, Fornace AJ, Jr. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res 2000; 60: 6101–10
   PubMed Web of Science ®Google Scholar
• Coronado PJ, Fasero M, Vidart JA, Puerta J, Magrina J, Furio‐Bacete V, Escudero M. A comparison of epithelial membrane antigen overexpression in benign and malignant endometrium. Gynecol Oncol 2001; 82: 483–8
   PubMed Web of Science ®Google Scholar
• Sivridis E, Giatromanolaki A, Koukourakis MI, Georgiou L, Anastasiadis P. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance. Histopathology 2002; 40: 92–100
   PubMed Web of Science ®Google Scholar
• Hudson MJ, Stamp GW, Chaudhary KS, Hewitt R, Stubbs AP, Abel PD, Lalani EN. Human MUC1 mucin: a potent glandular morphogen. J Pathol 2001; 194: 373–83
   PubMed Web of Science ®Google Scholar
• Aplin JD, Hey NA. MUC1, endometrium and embryo implantation. Biochem Soc Trans 1995; 23: 826–31
   PubMed Web of Science ®Google Scholar
• Mandelin E, Lassus H, Seppälä M, Leminen A, Gustafsson JA, Cheng G, Bützow R, Koistinen R. Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Cancer Res 2003; 63: 6258–64
   PubMed Web of Science ®Google Scholar
• Shabani N, Mylonas I, Kunert‐Keil C, Briese V, Janni W, Gerber B, Friese K, Jeschke U. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases. Anticancer Res 2005; 25: 1761–64
   PubMed Web of Science ®Google Scholar
• Swanton C. Cell‐cycle targeted therapies. Lancet Oncol 2004; 5: 27–36
   PubMed Web of Science ®Google Scholar
• Deans AJ, Khanna KK, McNees CJ, Mercurio C, Heierhorst J, McArthur GA. Cyclin‐dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1‐deficient cancers. Cancer Res 2006; 66: 8219–26
   PubMed Web of Science ®Google Scholar
• Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, Gomis RR, Manova‐Todorova K, Massague J. Mediators of vascular remodelling co‐opted for sequential steps in lung metastasis. Nature 2007; 446: 765–70
   PubMed Web of Science ®Google Scholar
• Wyatt CA, Geoghegan JC, Brinckerhoff CE. Short hairpin RNA‐mediated inhibition of matrix metalloproteinase‐1 in MDA‐231 cells: effects on matrix destruction and tumor growth. Cancer Res 2005; 65: 11101–8
   PubMed Web of Science ®Google Scholar
• Poola I, DeWitty RL, Marshalleck JJ, Bhatnagar R, Abraham J, Leffall LD. Identification of MMP‐1 as a putative breast cancer predictive marker by global gene expression analysis. Nat Med 2005; 11: 481–3
   PubMed Web of Science ®Google Scholar
• Williams TM, Lisanti MP. Caveolin‐1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005; 288: C494–506
   PubMed Web of Science ®Google Scholar
• Korah R, Das K, Lindy ME, Hameed M, Wieder R. Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium. Hum Pathol 2007; 38: 154–60
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 1999; 222: 124–38
   PubMed Web of Science ®Google Scholar
• Sloan EK, Stanley KL, Anderson RL. Caveolin‐1 inhibits breast cancer growth and metastasis. Oncogene 2004; 23: 7893–7
   PubMed Web of Science ®Google Scholar
• Liu D, Buluwela L, Ali S, Thomson S, Gomm JJ, Coombes RC. Retroviral infection of the FGF2 gene into MCF‐7 cells induces branching morphogenesis, retards cell growth and suppresses tumorigenicity in nude mice. Eur J Cancer 2001; 37: 268–80
   PubMed Web of Science ®Google Scholar
• Kenny PA, Bissell MJ. Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer 2003; 107: 688–95
   PubMed Web of Science ®Google Scholar
• Dolled‐Filhart M, McCabe A, Giltnane J, Cregger M, Camp RL, Rimm DL. Quantitative in situ analysis of β‐catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 2006; 66: 5487–94
   PubMed Web of Science ®Google Scholar
• Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006; 25: 1620–8
   PubMed Web of Science ®Google Scholar
• Arnold A, Papanikolaou A. Cyclin D1 in breast cancer pathogenesis. J Clin Oncol 2005; 23: 4215–24
   PubMed Web of Science ®Google Scholar
• Green DR, Evan GI. A matter of life and death. Cancer Cell 2002; 1: 19–30
   PubMed Web of Science ®Google Scholar
• Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen‐Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature 2000; 406: 747–52
   PubMed Web of Science ®Google Scholar
• Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain‐Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007; 11: 259–73
   PubMed Web of Science ®Google Scholar
• Campbell LL, Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution?. Cell Cycle 2007; 6: 2332–8
   PubMed Web of Science ®Google Scholar
• Seppälä M, Koistinen H, Koistinen R, Chiu PC, Yeung WS. Glycosylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations. Hum Reprod Update 2007; 13: 275–87
   PubMed Web of Science ®Google Scholar
• Yeung WS, Lee KF, Koistinen R, Koistinen H, Seppälä M, Ho PC, Chiu PC. Roles of glycodelin in modulating sperm function. Mol Cell Endocrinol 2006; 250: 149–56
   PubMed Web of Science ®Google Scholar
• Vaisse C, Atger M, Potier B, Milgrom E. Human placental protein 14 gene: sequence and characterization of a short duplication. DNA Cell Biol 1990; 9: 401–13
   PubMed Web of Science ®Google Scholar
• Van Cong N, Vaisse C, Gross MS, Slim R, Milgrom E, Bernheim A. The human placental protein 14 (PP14) gene is localized on chromosome 9q34. Hum Genet 1991; 86: 515–8
   PubMed Web of Science ®Google Scholar
• Garde J, Bell SC, Eperon IC. Multiple forms of mRNA encoding human pregnancy‐associated endometrial alpha 2‐globulin, a beta‐lactoglobulin homologue. Proc Natl Acad Sci USA 1991; 88: 2456–60
   PubMed Web of Science ®Google Scholar
• Morrow DM, Xiong N, Getty RR, Ratajczak MZ, Morgan D, Seppälä M, Riittinen L, Gewirtz AM, Tykocinski ML. Hematopoietic placental protein 14. An immunosuppressive factor in cells of the megakaryocytic lineage. Am J Pathol 1994; 145: 1485–95
   PubMed Web of Science ®Google Scholar
• Koistinen H, Koistinen R, Kämäräinen M, Salo J, Seppälä M. Multiple forms of messenger ribonucleic acid encoding glycodelin in male genital tract. Lab Invest 1997; 76: 683–90
   PubMed Web of Science ®Google Scholar
• Kämäräinen M, Halttunen M, Koistinen R, von Boguslawsky K, von Smitten K, Andersson LC, Seppälä M. Expression of glycodelin in human breast and breast cancer. Int J Cancer 1999; 83: 738–42
   PubMed Web of Science ®Google Scholar
• Flower DR. The lipocalin protein family: structure and function. Biochem J 1996; 318: 1–14
   PubMed Web of Science ®Google Scholar
• Bohn H, Kraus W, Winckler W. New soluble placental tissue proteins: their isolation, characterization, localization and quantification. Placenta Suppl 1982; 4: 67–81
   PubMedGoogle Scholar
• Julkunen M, Seppälä M, Jänne OA. Complete amino acid sequence of human placental protein 14: a progesterone‐regulated uterine protein homologous to β‐lactoglobulins. Proc Natl Acad Sci USA 1988; 85: 8845–9
   PubMed Web of Science ®Google Scholar
• Koistinen H, Koistinen R, Seppälä M, Burova TV, Choiset Y, Haertlé T. Glycodelin and β‐lactoglobulin, lipocalins with a high structural similarity, differ in ligand binding properties. FEBS Lett 1999; 450: 158–62
   PubMed Web of Science ®Google Scholar
• Chiu PC, Chung MK, Koistinen R, Koistinen H, Seppälä M, Ho PC, Ng EH, Lee KF, Yeung WS. Cumulus oophorus‐associated glycodelin‐C displaces sperm‐bound glycodelin‐A and ‐F and stimulates spermatozoa‐zona pellucida binding. J Biol Chem 2007; 282: 5378–88
   PubMed Web of Science ®Google Scholar
• Julkunen M. Human decidua synthesizes placental protein 14 (PP14) in vitro. Acta Endocrinol 1986; 112: 271–7
   PubMedGoogle Scholar
• Julkunen M, Rutanen EM, Koskimies A, Ranta T, Bohn H, Seppälä M. Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol 1985; 92: 1145–51
   PubMedGoogle Scholar
• Kämäräinen M, Leivo I, Koistinen R, Julkunen M, Karvonen U, Rutanen EM, Seppälä M. Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties. Am J Pathol 1996; 148: 1435–43
   PubMed Web of Science ®Google Scholar
• Tse JY, Chiu PC, Lee KF, Seppälä M, Koistinen H, Koistinen R, Yao YQ, Yeung WS. The synthesis and fate of glycodelin in human ovary during folliculogenesis. Mol Hum Reprod 2002; 8: 142–8
   PubMed Web of Science ®Google Scholar
• Julkunen M, Wahlström T, Seppälä M. Human fallopian tube contains placental protein 14. Am J Obstet Gynecol 1986; 154: 1076–9
   PubMed Web of Science ®Google Scholar
• Laird SM, Hill CJ, Warren MA, Tuckerman EM, Li TC. The production of placental protein 14 by human uterine tubal epithelial cells in culture. Hum Reprod 1995; 10: 1346–51
   PubMed Web of Science ®Google Scholar
• Saridogan E, Djahanbakhch O, Kervancioglu ME, Kahyaoglu F, Shrimanker K, Grudzinskas JG. Placental protein 14 production by human Fallopian tube epithelial cells in vitro. Hum Reprod 1997; 12: 1500–7
   PubMed Web of Science ®Google Scholar
• Kämäräinen M, Riittinen L, Seppälä M, Palotie A, Andersson LC. Progesterone‐associated endometrial protein‐a constitutive marker of human erythroid precursors. Blood 1994; 84: 467–73
   PubMed Web of Science ®Google Scholar
• Tseng L, Zhu HH, Mazella J, Koistinen H, Seppälä M. Relaxin stimulates glycodelin mRNA and protein concentrations in human endometrial glandular epithelial cells. Mol Hum Reprod 1999; 5: 372–5
   PubMed Web of Science ®Google Scholar
• Taylor RN, Vigne JL, Zhang P, Hoang P, Lebovic DI, Mueller MD. Effects of progestins and relaxin on glycodelin gene expression in human endometrial cells. Am J Obstet Gynecol 2000; 182: 841–7
   PubMed Web of Science ®Google Scholar
• Oehninger S, Coddington CC, Hodgen GD, Seppälä M. Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida. Fertil Steril 1995; 63: 377–83
   PubMed Web of Science ®Google Scholar
• Chiu PC, Koistinen R, Koistinen H, Seppälä M, Lee KF, Yeung WS. Binding of zona binding inhibitory factor‐1 (ZIF‐1) from human follicular fluid on spermatozoa. J Biol Chem 2003; 278: 13570–7
   PubMed Web of Science ®Google Scholar
• Chiu PC, Chung MK, Koistinen R, Koistinen H, Seppälä M, Ho PC, Ng EH, Lee KF, Yeung WS. Glycodelin‐A interacts with fucosyltransferase on human sperm plasma membrane to inhibit spermatozoa‐zona pellucida binding. J Cell Sci 2007; 120: 33–44
   PubMed Web of Science ®Google Scholar
• Chiu PC, Chung MK, Tsang HY, Koistinen R, Koistinen H, Seppälä M, Lee KF, Yeung WS. Glycodelin‐S in human seminal plasma reduces cholesterol efflux and inhibits capacitation of spermatozoa. J Biol Chem 2005; 280: 25580–9
   PubMed Web of Science ®Google Scholar
• Chiu PC, Koistinen R, Koistinen H, Seppälä M, Lee KF, Yeung WS. Zona‐binding inhibitory factor‐1 from human follicular fluid is an isoform of glycodelin. Biol Reprod 2003; 69: 365–72
   PubMed Web of Science ®Google Scholar
• Clark GF, Oehninger S, Patankar MS, Koistinen R, Dell A, Morris HR, Koistinen H, Seppälä M. A role for glycoconjugates in human development: the human feto‐embryonic defence system hypothesis. Hum Reprod 1996; 11: 467–73
   PubMed Web of Science ®Google Scholar
• Bolton AE, Pockley AG, Clough KJ, Mowles EA, Stoker RJ, Westwood OM, Chapman MG. Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet 1987; 1: 593–55
   PubMed Web of Science ®Google Scholar
• Okamoto N, Uchida A, Takakura K, Kariya Y, Kanzaki H, Riittinen L, Koistinen R, Seppälä M, Mori T. Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol 1991; 26: 137–42
   PubMed Web of Science ®Google Scholar
• Rachmilewitz J, Riely GJ, Huang JH, Chen A, Tykocinski ML. A rheostatic mechanism for T‐cell inhibition based on elevation of activation thresholds. Blood 2001; 98: 3727–32
   PubMed Web of Science ®Google Scholar
• Rachmilewitz J, Riely GJ, Tykocinski ML. Placental protein 14 functions as a direct T‐cell inhibitor. Cell Immunol 1999; 191: 26–33
   PubMed Web of Science ®Google Scholar
• Yaniv E, Borovsky Z, Mishan‐Eisenberg G, Rachmilewitz J. Placental protein 14 regulates selective B cell responses. Cell Immunol 2003; 222: 156–63
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay D, SundarRaj S, Alok A, Karande AA, Glycodelin A, not glycodelin S, is apoptotically active. Relevance of sialic acid modification. J Biol Chem 2004; 279: 8577–84
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay D, Sundereshan S, Rao C, Karande AA. Placental protein 14 induces apoptosis in T cells but not in monocytes. J Biol Chem 2001; 276: 28268–73
   PubMed Web of Science ®Google Scholar
• Tee MK, Vigne JL, Yu J, Taylor RN. Natural and recombinant human glycodelin activate a proapoptotic gene cascade in monocyte cells. J Leukoc Biol 2008; 83: 843–52
   PubMed Web of Science ®Google Scholar
• SundarRaj S, Mukhopadhyay D, Karande AA. Glycodelin A triggers mitochondrial stress and apoptosis in T cells by a mechanism distinct and independent of TCR signaling. Mol Immunol 2008; 45: 2391–400
   PubMed Web of Science ®Google Scholar
• Dalton CF, Laird SM, Estdale SE, Saravelos HG, Li TC. Endometrial protein PP14 and CA‐125 in recurrent miscarriage patients: correlation with pregnancy outcome. Hum Reprod 1998; 13: 3197–202
   PubMed Web of Science ®Google Scholar
• Tulppala M, Julkunen M, Tiitinen A, Stenman UH, Seppälä M. Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle. Fertil Steril 1995; 63: 792–5
   PubMed Web of Science ®Google Scholar
• Koistinen H, Easton RL, Chiu PC, Chalabi S, Halttunen M, Dell A, Morris HR, Yeung WS, Seppälä M, Koistinen R. Differences in glycosylation and sperm‐egg binding inhibition of pregnancy‐related glycodelin. Biol Reprod 2003; 69: 1545–51
   PubMed Web of Science ®Google Scholar
• Koistinen H, Koistinen R, Dell A, Morris HR, Easton RL, Patankar MS, Oehninger S, Clark GF, Seppälä M. Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin‐A. Mol Hum Reprod 1996; 2: 759–65
   PubMed Web of Science ®Google Scholar